Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 2
2011 1
2013 1
2014 1
2015 1
2016 1
2017 1
2018 3
2019 2
2020 1
2021 1
2022 2
2023 2
2024 4
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitor-associated myocarditis: a novel risk score.
Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, Cautela J, Courand PY, Hayek SS, Zhu H, Zaha VG, Cheng RK, Alexandre J, Roubille F, Baldassarre LA, Chen YC, Baik AH, Laufer-Perl M, Tamura Y, Asnani A, Francis S, Gaughan EM, Rainer PP, Bailly G, Flint D, Arangalage D, Cariou E, Florido R, Narezkina A, Liu Y, Sandhu S, Leong D, Issa N, Piriou N, Heinzerling L, Peretto G, Crusz SM, Akhter N, Levenson JE, Turker I, Eslami A, Fenioux C, Moliner P, Obeid M, Chan WT, Ewer SM, Kassaian SE, Johnson DB, Nohria A, Ben Zadok OI, Moslehi JJ, Salem JE; International ICI-Myocarditis Registry. Power JR, et al. Eur Heart J. 2025 Jun 18:ehaf315. doi: 10.1093/eurheartj/ehaf315. Online ahead of print. Eur Heart J. 2025. PMID: 40569849 Free article.
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
Zurko J, Ramdial J, Shadman M, Ahmed S, Szabo A, Iovino L, Tomas AA, Sauter C, Perales MA, Shah NN, Acharya UH, Jacobson C, Soiffer RJ, Wang T, Komanduri KV, Jaglowski S, Kittai AS, Denlinger N, Iqbal M, Kharfan-Dabaja MA, Ayala E, Chavez J, Jain M, Locke FL, Samara Y, Budde LE, Mei MG, Pia AD, Feldman T, Ahmed N, Jacobs R, Ghosh N, Dholaria B, Oluwole OO, Hess B, Hassan A, Kenkre VP, Reagan P, Awan F, Nieto Y, Hamadani M, Herrera AF. Zurko J, et al. Among authors: samara y. Haematologica. 2023 Jan 1;108(1):98-109. doi: 10.3324/haematol.2022.281242. Haematologica. 2023. PMID: 35833303 Free PMC article.
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect.
Koller PB, Othman T, Yang D, Mokhtari S, Samara Y, Blackmon A, Agrawal V, Pourhassan H, Ball BJ, Amanam I, Arslan S, Otoukesh S, Sandhu KS, Aldoss I, Ali H, Salhotra A, Aribi A, Artz A, Becker PS, Pullarkat V, Stewart FM, Smith EP, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Koller PB, et al. Among authors: samara y. Bone Marrow Transplant. 2025 May;60(5):625-631. doi: 10.1038/s41409-025-02523-3. Epub 2025 Feb 27. Bone Marrow Transplant. 2025. PMID: 40016513 Free PMC article.
Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation.
Desai A, Samara Y, Yang D, Ball B, Braun A, Koller P, Blackmon A, Agrawal V, Pourhassan H, Amanam I, Arslan S, Otoukesh S, Sandhu K, Aldoss I, Ali H, Salhotra A, Al Malki MM, Artz A, Becker P, Smith E, Stein A, Marcucci G, Forman SJ, Curtin P, Nakamura R, Pullarkat V. Desai A, et al. Among authors: samara y. Leuk Res. 2024 Oct;145:107565. doi: 10.1016/j.leukres.2024.107565. Epub 2024 Aug 25. Leuk Res. 2024. PMID: 39208597
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation.
Arslan S, Desai A, Yang D, Mokhtari S, Tiemann K, Otoukesh S, Samara Y, Blackmon A, Agrawal V, Pourhassan H, Amanam I, Ball B, Koller P, Salhotra A, Aribi A, Becker P, Curtin P, Artz A, Aldoss I, Ali H, Stewart F, Smith E, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Arslan S, et al. Among authors: samara y. Transplant Cell Ther. 2024 Oct;30(10):1013.e1-1013.e12. doi: 10.1016/j.jtct.2024.08.005. Epub 2024 Aug 8. Transplant Cell Ther. 2024. PMID: 39122188 Free PMC article.
Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high-risk relapsed/refractory Hodgkin lymphoma.
Mei M, Palmer J, Lee HJ, Isufi I, Chen R, Tsai NC, Armenian S, Godfrey J, Song JY, Baird JH, Thiruvengadam S, Samara Y, Flores J, Peters L, Rosen S, Kwak L, Forman SJ, Herrera AF. Mei M, et al. Among authors: samara y. Hemasphere. 2025 Apr 30;9(5):e70126. doi: 10.1002/hem3.70126. eCollection 2025 May. Hemasphere. 2025. PMID: 40313510 Free PMC article.
Purple bowel misdiagnosed as intestinal hemorrhage.
Abderrahman HA, Al-Abdallat IM, Alsenaidi LK, Samara YF, Allouzi DK, Ishtaieh SA, Abuzaid LA. Abderrahman HA, et al. Among authors: samara yf. J Forensic Leg Med. 2025 Apr;111:102833. doi: 10.1016/j.jflm.2025.102833. Epub 2025 Feb 21. J Forensic Leg Med. 2025. PMID: 40010203
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis.
Samuels DT, Yao JM, Samara Y, Yang D, Mokhtari S, Tiemann K, Otoukesh S, Arslan S, Pourhassan H, Wu S, Blackmon A, Agrawal V, Amanam I, Ali H, Salhotra A, Aldoss I, Ball B, Koller P, Aribi A, Sandhu K, Pullarkat V, Artz A, Smith E, Stewart F, Becker P, Stein A, Marcucci G, Forman SJ, Nakamura R, Al Malki MM. Samuels DT, et al. Among authors: samara y. Front Immunol. 2025 Feb 20;16:1543099. doi: 10.3389/fimmu.2025.1543099. eCollection 2025. Front Immunol. 2025. PMID: 40051639 Free PMC article.
30 results